Researchers evaluated the proficiency of Generative Pre-trained Transformer 4 (GPT-4) AI in probabilistic reasoning compared to human clinicians by assessing pretest and posttest probability estimates in diagnostic cases.
BMB-101 by Bright Minds Biosciences for Seizures: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes